Relations between strain and gender dependencies of irinotecan toxicity and UGT1A1, CES2 and TOP1 expressions in mice. Ahowesso, C, Piccolo, E, Li, X M, Dulong, S, Hossard, V, La Sorda, R, Filipski, E, Tinari, N, Delaunay, F, Iacobelli, S, & Lévi, F Toxicol Lett, 192(3):395–401, 2010.
Relations between strain and gender dependencies of irinotecan toxicity and UGT1A1, CES2 and TOP1 expressions in mice [link]Paper  abstract   bibtex   
Irinotecan hydrochloride (CPT-11) can display severe toxicities in individual cancer patients. CPT-11 is bio-activated through CES, detoxified through UGT1A1 and inhibits TOP1. CPT-11 toxicity and UGT1A1, CES2 and TOP1 mRNAs and UGT1A1 protein were determined in male and female C57BL/6, B6D2F1 and B6CBAF1, as potential models for tailoring CPT-11 delivery. CPT-11 was administered intravenously (40-90 mg/kg/day for 4 days at 7h after light onset). The relations between dose and lethal toxicity or body weight loss were steep and similar in C57BL/6 (lethality, p=0.001; weight loss, p=0.002) and B6D2F1 (p=0.01; p=0.03, respectively), but weak in B6CBAF1. Females displayed less toxicity than males (p\textless0.001). Mean mRNA expression of UGT1A1 was highest in B6CBAF1 (p=0.039) and in females (p\textless0.001). Both CES2 and TOP1 varied according to strain and gender (p\textless0.001). The three gene expression data explained the most severe toxicity of CPT-11 in male B6D2F1, but displayed inconsistent relations with toxicity in the other groups. Mean UGT1A1 protein expression was highest in males as compared to females, and so by approximately 8-fold in C57BL/6 as compared to B6D2F1 (p\textless0.0001). Genetic background and gender significantly altered the molecular prediction of irinotecan toxicity by UGT1A1, CES2 and TOP1 mRNA expressions.
@article{ahowesso_relations_2010,
	title = {Relations between strain and gender dependencies of irinotecan toxicity and {UGT1A1}, {CES2} and {TOP1} expressions in mice},
	volume = {192},
	issn = {1879-3169},
	shorttitle = {Relations between strain and gender dependencies of irinotecan toxicity and {UGT1A1}, {CES2} and {TOP1} expressions in mice},
	url = {http://dx.doi.org/10.1016/j.toxlet.2009.11.017},
	abstract = {Irinotecan hydrochloride (CPT-11) can display severe toxicities in individual cancer patients. CPT-11 is bio-activated through CES, detoxified through UGT1A1 and inhibits TOP1. CPT-11 toxicity and UGT1A1, CES2 and TOP1 mRNAs and UGT1A1 protein were determined in male and female C57BL/6, B6D2F1 and B6CBAF1, as potential models for tailoring CPT-11 delivery. CPT-11 was administered intravenously (40-90 mg/kg/day for 4 days at 7h after light onset). The relations between dose and lethal toxicity or body weight loss were steep and similar in C57BL/6 (lethality, p=0.001; weight loss, p=0.002) and B6D2F1 (p=0.01; p=0.03, respectively), but weak in B6CBAF1. Females displayed less toxicity than males (p{\textless}0.001). Mean mRNA expression of UGT1A1 was highest in B6CBAF1 (p=0.039) and in females (p{\textless}0.001). Both CES2 and TOP1 varied according to strain and gender (p{\textless}0.001). The three gene expression data explained the most severe toxicity of CPT-11 in male B6D2F1, but displayed inconsistent relations with toxicity in the other groups. Mean UGT1A1 protein expression was highest in males as compared to females, and so by approximately 8-fold in C57BL/6 as compared to B6D2F1 (p{\textless}0.0001). Genetic background and gender significantly altered the molecular prediction of irinotecan toxicity by UGT1A1, CES2 and TOP1 mRNA expressions.},
	number = {3},
	journal = {Toxicol Lett},
	author = {Ahowesso, C and Piccolo, E and Li, X M and Dulong, S and Hossard, V and La Sorda, R and Filipski, E and Tinari, N and Delaunay, F and Iacobelli, S and Lévi, F},
	year = {2010},
	pages = {395--401},
}

Downloads: 0